A new model based on preoperative AFP, albumin, and tumor burden score for predicting microvascular invasion in early-stage HCC
American Journal of Cancer Research · 2024 · 14 (10) · 4979-4988
DOI: 10.62347/zgrj7827 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Cancer Research, 2024. Verfasst von Yuan-Sheng Chang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Med…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Microscopic vascular invasion (MVI) has been demonstrated as a strong risk factor associated with tumor recurrence and poor overall survival among hepatocellular carcinoma (HCC) patients after resection, but the preoperative prediction of MVI is still challenging. We aimed to build and validate a novel model to predict MVI in the preoperative setting. We retrospectively collected 857 patients with Barcelona Clinic Liver Cancer (BCLC) stage 0 or A HCC who underwent primary resection at Kaohsiung Chang Gung Hospital between January 2001 and June 2016. The patients were randomized into derivation (n = 648) and validation groups (n = 209). Logistic regression analysis was used to screen out independent risk factors for MVI and further constructed a predictive model for MVI. Prediction performance was compared by the area under the receiver operating characteristic curve (AUC). The multivariable logistic regression analysis of the training cohort found that alpha-fetoprotein (AFP) ≥ 20 ng/mL (OR = 1.96, 95% CI: 1.41-2.73, P < 0.001), albumin < 3.5 g/dL (OR = 1.48, 95% CI: 1.06-2.05, P = 0.019) and tumor burden score (TBS) ≥ 8.6 (OR = 2.54, 95% CI: 1.49-4.35, P = 0.001) to be independent risk factors for MVI. The three factors were chosen to build a model for prediction of MVI. The AUC for the training and validation group was 0.619 (95% CI: 0.575-0.663) and 0.642 (95% CI: 0.562-0.722), respectively, and the calibration plot showed good performance of the prediction model, with a low mean absolute error at 0.01. In conclusion, the new model comprised AFP, albumin, and TBS that can predict risk of MVI for early-stage HCC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine Kaohsiung, Taiwan.
- School of Medicine, Kaohsiung Medical University Hospital Kaohsiung, Taiwan.
- Kaohsiung Municipal Kaohsiung Senior High School Kaohsiung, Taiwan.
- Division of General Surgery, Department of Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine Kaohsiung, Taiwan.
- Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine Kaohsiung, Taiwan.
- School of Medicine, College of Medicine, National Sun Yat-sen University Kaohsiung, Taiwan.
Zitieren
APA
Chang, Y. S., Tsai, M. J., Tsai, C. J., Wang, C. C., Lin, C. C., Yen, Y. H., Hung, C. H., Kuo, Y. H., Huang, D. S., Tai, W. C., Hu, T. H., & Tsai, M. C. (2024). A new model based on preoperative AFP, albumin, and tumor burden score for predicting microvascular invasion in early-stage HCC. American Journal of Cancer Research, 14(10), 4979-4988. https://doi.org/10.62347/zgrj7827
Vancouver
Chang YS, Tsai MJ, Tsai CJ, Wang CC, Lin CC, Yen YH, et al. A new model based on preoperative AFP, albumin, and tumor burden score for predicting microvascular invasion in early-stage HCC. American Journal of Cancer Research. 2024;14(10):4979-4988. doi:10.62347/zgrj7827
BibTeX
@article{Chang2024,
author = {Chang, Yuan-Sheng and Tsai, Mu-Jung and Tsai, Chieh-Jui and Wang, Chih-Chi and Lin, Chih-Che and Yen, Yi-Hao and Hung, Chao-Hung and Kuo, Yuan-Hung and Huang, Ding-Sen and Tai, Wei-Chen and Hu, Tsung-Hui and Tsai, Ming-Chao},
title = {A new model based on preoperative AFP, albumin, and tumor burden score for predicting microvascular invasion in early-stage HCC},
journal = {American Journal of Cancer Research},
year = {2024},
volume = {14},
number = {10},
pages = {4979--4988},
doi = {10.62347/zgrj7827}
}
EUVIMED